Zhejiang Jiuzhou Pharmaceutical Co., Ltd.SSE: 603456

(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Progress of the Wholly-owned Subsidiary's Participation in the Investment in Jiaxing Longfeng Venture Capital Partnership (Limited Partnership)

· Issued by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603456 · · 4 pages · Chinese

Summary by 6ix AI

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has announced the progress of its wholly-owned subsidiary's investment in Jiaxing Longfeng Venture Capital Partnership. The filing details the investment amount and the status of the partnership, including the addition of new partners and their contributions. The company assures that this investment will not significantly affect its financial status or operational results.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603456zhejiang-jiuzhou-pharmaceutical-co-ltdannouncement-on-progress-of-the-wholly-owned-subsidiarys-participation-in-the-investment-in-jiaxing-longfeng-venture-capital-partnership-limited-partnership

Release

Announcement on Progress of the Wholly-owned Subsidiary's Participation in the Investment in Jiaxing Longfeng Venture Capital Partnership (Limited Partnership)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Zhejiang Jiuzhou Pharmaceutical

Later from Zhejiang Jiuzhou Pharmaceutical

All Zhejiang Jiuzhou Pharmaceutical news releases